Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions